SEC Form 4 · accession 0001213900-16-018868
ORAMED PHARMACEUTICALS INC. · ORMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joshua Hexter
Officer — Chief Operating Officer
Period of report
Nov 1, 2016
Accepted (ET)
Nov 22, 2016 · 3:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001176309
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 1, 2016 | A | 70,000 | $0.00 | A | 70,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares vest as follows: 9,000 shares vest immediately; 1,500 shares will vest in 18 consecutive installments on the last day of each month commencing November 30, 2016; and 17,000 will vest in each of April 30, 2017 and April 30, 2018.